Clinical trial
Dose Determination Safety and Activity Study of Inhaled NX1011 to Treat…
NCT00323024 · NITROX, LLC, Industry · Withdrawn
Key facts
| NCT number | NCT00323024 |
|---|---|
| Title | Dose Determination Safety and Activity Study of Inhaled NX1011 to Treat Pulmonary Arterial Hypertension |
| Official title | An Open-Label, Dose-Determination Safety, Tolerability, and Activity Study of Inhaled NX1011 in Patients With Pulmonary Arterial Hypertension |
| Lead sponsor | NITROX, LLC, Industry |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pulmonary Hypertension |
| Intervention type | Drug |
| Interventions | NX1011 |
| Enrollment | 72 |
| Start date | Sep 1, 2006 |
| Completion | May 1, 2007 |
| First posted | May 9, 2006 |
| Last update posted | Aug 30, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: